LEADER 04263nam 22006133u 450 001 996339109903316 005 20230725024542.0 010 $a1-282-70154-1 010 $a9786612701542 010 $a1-84692-605-X 035 $a(CKB)2670000000035010 035 $a(EBL)601463 035 $a(OCoLC)656579554 035 $a(SSID)ssj0000426110 035 $a(PQKBManifestationID)12109355 035 $a(PQKBTitleCode)TC0000426110 035 $a(PQKBWorkID)10372459 035 $a(PQKB)10830412 035 $a(MiAaPQ)EBC601463 035 $a(EXLCZ)992670000000035010 100 $a20130418d2010|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aProblem Solving in Haematology$b[electronic resource] 210 $aOxford $cClinical Publishing$d2010 215 $a1 online resource (210 p.) 225 1 $aProblem Solving 300 $aDescription based upon print version of record. 311 $a1-84692-005-1 327 $aContents; Contributors; Abbreviations; Section 1: Introduction; Problem 01: The approach to the patient with anabnormal blood count; Section 2: Haemostasis and Thrombosis; Problem 02: Anticoagulation; Problem 03: Bleeding in an intensive therapy unitpatient; Problem 04: Investigation of easy bruising; Problem 05: Inherited disorders of coagulation; Problem 06: Thrombophilia; Section 3: Red Cell Disorders and Aplastic Anaemia; Problem 07: The investigation of anaemia and theanaemia of chronic disease; Problem 08: Aplastic anaemia; Problem 09: Paroxysmal nocturnal haemoglobinuria 327 $aProblem 10: Sickle cell diseaseProblem 11: ß-Thalassaemia major; Section 4: Clinical Blood Transfusion; Problem 12: Acute haemolytic transfusion reaction(ABO incompatibility); Problem 13: Massive blood transfusion; Problem 14: Refractoriness to platelet transfusion; Problem 15: Transfusion-related acute lung injury; Section 5: Acute and Chronic Leukaemia andMyelodysplasia; Problem 16: Acute myeloid leukaemia; Problem 17: Paediatric acute lymphoblasticleukaemia; Problem 18: Adult acute lymphoblastic leukaemia; Problem 19: Chronic lymphocytic leukaemia - earlystage disease 327 $aProblem 20: Chronic lymphocytic leukaemia -advanced stage diseaseProblem 21: Chronic myeloid leukaemia; Problem 22: Low-risk myelodysplastic syndrome; Section 6: Myeloproliferative Disorders; Problem 23: Primary polycythaemia; Problem 24: Primary myelofibrosis; Problem 25: Essential thrombocythaemia; Problem 26: Hypereosinophilic syndrome; Section 7: Lymphoma; Problem 27: Hodgkin lymphoma - early stagedisease; Problem 28: Hodgkin lymphoma - advanced stagedisease and long-term sequelae; Problem 29: High-grade diffuse largeB-cell non-Hodgkin lymphoma 327 $aProblem 30: Primary central nervous systemlymphomaProblem 31: Indolent lymphoma - follicular non-Hodgkin lymphoma; Problem 32: Indolent lymphoma - Waldenstro?m'smacroglobulinaemia epistaxis; Section 8: Plasma Cell Disorders; Problem 33: Myeloma - diagnosis and prognosis; Problem 34: Myeloma - management; Problem 35: Myeloma - treatment in the less fit orcompromised patient; Problem 36: Myeloma - solitary plasmacytoma; Problem 37: Myeloma - AL amyloid; Index 330 $aAn experienced panel lead readers through real-life clinical presentations on how to diagnose and manage a variety of clinical cases seen in haematology practice. Over 30 common and challenging clinical scenarios create a foundation for learning and revision that incorporates recent medical literature and presents the latest guidelines for management. Contributors outline treatment strategies for each case, with accompanying algorithms and illustrations in many cases. 410 0$aProblem Solving 606 $aBlood -- Diseases 606 $aHematologic Diseases 606 $aHematology 615 4$aBlood -- Diseases. 615 4$aHematologic Diseases. 615 4$aHematology. 676 $a616.1/5 700 $aSmith$b Graeme$0851898 701 $aCook$b Gordon$01008365 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339109903316 996 $aProblem Solving in Haematology$92325652 997 $aUNISA